Physician profile
Michael L Harris
NPI 1215964762
$348.65
in general payments reported to CMS, 2019-2025
8 companies · $60.59 in 2025
The $60.59 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.07 · 2020: $17.06 · 2021: $18.85 · 2022: $42.79 · 2023: $143 · 2024: $47.73 · 2025: $60.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $234 · Education: $17.19.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $233.69 |
| Education | $17.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $124.99 | 2023 | Tepezza |
| Abbvie INC. | $65.15 | 2024-2025 | |
| Alcon Vision LLC | $52.35 | 2019-2022 | |
| Rxsight INC | $28.36 | 2022 | |
| Viiv Healthcare Company | $25.98 | 2025 | Apretude |
| Johnson & Johnson Surgical Vision, INC. | $17.57 | 2023 | Tecnis Iol |
| Apellis Pharmaceuticals, INC. | $17.19 | 2024 | Syfovre |
| Carl Zeiss Meditec, INC. | $17.06 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.